Illumina, Inc. v. BGI Genomics Co., Ltd
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ILLUMINA INC., et al., DISCOVERY ORDER Plaintiffs, Case No. 20-cv-01465-WHO (TSH) ECF Nos. 365, 387, 394, 396, 403 v.
BGI GENOMICS CO., LTD., et al., Case No. 19-cv-03770-WHO (TSH) ECF Nos. 351, 366, 368, 370, 375 Defendants.
The parties have a fight about some of Defendants’ claims of attorney-client privilege. First, the Court will retrace how we got here. Then the Court will address some procedural disputes. Then the Court will rule on the merits and address whether there should be any next steps. A. Procedural Background Fact discovery closed on March 26, 2021. See ECF No. 2491. On March 31, 2021, before the deadline to move to compel expired, the parties filed a joint discovery letter brief (ECF No. 314), in which Illumina sought several forms of relief. It asked the Court to order Defendants to produce a privilege log, asserting that they had not yet produced a log for their unproduced and clawed back…